IBUPROFEN
| Brand name | CALDOLOR |
|---|---|
| Active ingredient | IBUPROFEN |
| Strength | 400MG/4ML (100MG/ML) |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | June 2009 |
| Marketing status | DISCN |
| Code | Expires |
|---|---|
| NPP | May 2026 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.